Status:
COMPLETED
Femoral Artery Hemostasis Without Manual Compression
Lead Sponsor:
Second Xiangya Hospital of Central South University
Conditions:
Femoral Arterial Hemostasis
Eligibility:
All Genders
Phase:
NA
Brief Summary
FAST trial is a prospective, randomized, controlled, multicenter study in participants needing hemostasis after femoral arterial puncture. All eligible participants will be randomly assigned to either...
Detailed Description
The common femoral artery is the most frequently used access site in cardiovascular interventional therapy. Closure of the arteriotomy site is usually achieved by manual compression after femoral arte...
Eligibility Criteria
Inclusion
- Patients undergoing femoral access cardiovascular interventional therapy
- Patient must be competent for providing informed written consent
Exclusion
- Peripheral arterial occlusive disease
- Prior peripheral artery surgery
- Critical limb ischemic
- Femoral arterial intubation failure
- Uncontrolled hypertension \>220/110 mmHg
- Coagulopathy (bleeding disorder)
- Local infection
- Pregnancy
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT04689555
Start Date
January 1 2021
End Date
December 31 2022
Last Update
April 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China, 410011